These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 25824228

  • 1. In vitro activities of amphotericin B, terbinafine, and azole drugs against clinical and environmental isolates of Aspergillus terreus sensu stricto.
    Fernández MS, Rojas FD, Cattana ME, Sosa Mde L, Iovannitti CA, Lass-Flörl C, Giusiano GE.
    Antimicrob Agents Chemother; 2015; 59(6):3619-22. PubMed ID: 25824228
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD, Kiraz N.
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [Abstract] [Full Text] [Related]

  • 10. Species Identification and In Vitro Antifungal Susceptibility of Aspergillus terreus Species Complex Clinical Isolates from a French Multicenter Study.
    Imbert S, Normand AC, Ranque S, Costa JM, Guitard J, Accoceberry I, Bonnal C, Fekkar A, Bourgeois N, Houzé S, Hennequin C, Piarroux R, Dannaoui E, Botterel F.
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439956
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B against Azole-Susceptible and -Resistant Aspergillus Section Fumigati Clinical Isolates.
    Dellière S, Verdurme L, Bigot J, Dannaoui E, Senghor Y, Botterel F, Fekkar A, Bougnoux ME, Hennequin C, Guitard J.
    Antimicrob Agents Chemother; 2020 Feb 21; 64(3):. PubMed ID: 31844011
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin B.
    Moore CB, Walls CM, Denning DW.
    Antimicrob Agents Chemother; 2001 Jun 21; 45(6):1882-5. PubMed ID: 11353643
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun 21; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro antifungal susceptibility of clinically relevant species belonging to Aspergillus section Flavi.
    Gonçalves SS, Stchigel AM, Cano J, Guarro J, Colombo AL.
    Antimicrob Agents Chemother; 2013 Apr 21; 57(4):1944-7. PubMed ID: 23335742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E, Pemán J, Valverde A, Chaves M, Serrano MC, Cantón E.
    J Antimicrob Chemother; 2003 Sep 21; 52(3):365-70. PubMed ID: 12917236
    [Abstract] [Full Text] [Related]

  • 19. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR, Lau YJ, Chuang YC, Wan JH, Huang WK, Shyr JM, Yan JJ, Yu KW, Wu JJ, Ko WC, Yang YC, Liu YC, Teng LJ, Liu CY, Luh KT.
    Antimicrob Agents Chemother; 2005 Feb 21; 49(2):512-7. PubMed ID: 15673726
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
    Borba-Santos LP, Rodrigues AM, Gagini TB, Fernandes GF, Castro R, de Camargo ZP, Nucci M, Lopes-Bezerra LM, Ishida K, Rozental S.
    Med Mycol; 2015 Feb 01; 53(2):178-88. PubMed ID: 25394542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.